December 7, 2021

Deep Lens Announces Launch of Real Time Feasibility Offering to Assist in Oncology Clinical Trial Design and Site Selection

Columbus, OH – December 7, 2021 – Deep Lens, a digital healthcare company focused on revolutionizing the oncology clinical trial recruitment process through artificial intelligence solutions, today announced the launch of its Real Time Feasibility offering, a new HIPAA-compliant tool designed to identify eligible patients and select the most effective […]
November 8, 2021

Precision for Medicine CIR (French Research Tax Credit) Accreditation Updates

PARIS, FRANCE –  25 October 2021 — Precision for Medicine, the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively, today announced that it has received updated CIR accreditation from the French Ministry of Higher Education […]
August 5, 2021

Precision for Medicine Announces Partnership with Trialbee to Expand and Accelerate Clinical Trial Recruitment

Precision for Medicine and Trialbee Partner to Advance Clinical Trials for Complex Therapies and Speed Shift Toward Precision Medicine     MALMO, SWEDEN & BETHESDA, MD — August 5, 2021 – Clinical research organization Precision for Medicine and Trialbee, a patient matching and enrollment platform, are […]
January 14, 2021

Precision Medicine Group Significantly Expands Cell and Gene Therapy Expertise with Acquisition of Project Farma

LEADING BIO-ENGINEERING AND MANUFACTURING SERVICES FIRM CATALYZES THE LAUNCH OF PRECISION’S CELL AND GENE THERAPY OFFERING—’PRECISION ADVANCE’—ADDRESSING THE UNIQUE CHALLENGES OF CELL & GENE THERAPY INNOVATORS, FROM DEVELOPMENT THROUGH COMMERCIALIZATION BETHESDA, MD—January 14, 2021—Precision Medicine Group (“PMG”) announced today it has acquired Project Farma, a patient-focused bioengineering services firm that […]
September 17, 2020

Precision nominated for “Best CRO” by OBN Awards

Precision for Medicine is excited to be named as one of three finalists for an OBN Award 2020 in the Best CRO category! Congratulations to our fellow finalists. The OBN Awards celebrate the UK’s most innovative life sciences companies. https://lnkd.in/dQK—x
May 17, 2020

Mark Clein, Co-Founder and CEO of Precision Medicine Group, delivers the keynote address for BioTrinity 2020

You can view his address at your convenience here. In the course of his presentation you will hear: The ways in which digital technology is transforming patient care and impacting clinical trials What new breakthroughs are on the horizon How precision medicine continues to advance and affect patient treatment and […]
May 1, 2020

How Precision is responding to COVID-19

Protecting our employees, continuing the important work of our clients Precision for Medicine, part of Precision Medicine Group’s global team of pharmaceutical and life science experts, is diligently monitoring and complying with the latest state, national, and international regulatory guidelines surrounding the COVID-19 pandemic commonly known as the “coronavirus.” While […]
April 21, 2020

Precision for Medicine Partners with Karyopharm Therapeutics to Initiate New Global Clinical Trial to Treat Patients with COVID-19

PRECISION FOR MEDICINE PARTNERS WITH KARYOPHARM THERAPEUTICS TO INITIATE NEW GLOBAL CLINICAL TRIAL TO TREAT PATIENTS WITH COVID-19 — First Study of an XPO1 Inhibitor to Treat Patients with Severe Viral Infections — Precision for Medicine Responsible for Clinical Trial Management in Europe BUDAPEST, April 22, 2020 – Precision for […]
April 2, 2020

EVICTION Trial to Evaluate Anti-cancer Drug ICT01 Launches

First-in-human, international, multi-center trial to test Butyrophylin 3A-targeted antibody in advanced solid and hematologic tumors – Precision provides global central lab support and US site management Marseille, France, March 26, 2020 – ImCheck Therapeutics announced today that it has dosed the first patient in a Phase I/IIa clinical trial evaluating […]